Stanford University
Showing 1-50 of 175 Results
-
Amirsaman Ashtari
Postdoctoral Scholar, Radiation Biology
BioI am a postdoctoral researcher at Stanford University, jointly supervised by Ash Alizadeh MD/PhD and Mohammad Shahrokh Esfahani PhD. I developed several AI solutions for the Computer Vision and Computer Graphic domains during my PhD studies at KAIST and ETH Zurich. My PhD research outcome was recognized by winning the Young Researcher Award, and I was eager to apply all those AI techniques to biological data for cancer therapy. In the Alizadeh and Esfahani labs, I will develop AI solutions and computational tools to better understand the tumor microenvironment. Outside of my research, I enjoy loving my family, playing the piano, and listening to music.
-
Laura Attardi
Catharine and Howard Avery Professor of the School of Medicine and Professor of Genetics
Current Research and Scholarly InterestsOur research is aimed at defining the pathways of p53-mediated apoptosis and tumor suppression, using a combination of biochemical, cell biological, and mouse genetic approaches. Our strategy is to start by generating hypotheses about p53 mechanisms of action using primary mouse embryo fibroblasts (MEFs), and then to test them using gene targeting technology in the mouse.
-
Mohsen Bayati
Carl and Marilynn Thoma Professor in the Graduate School of Business and Professor, by courtesy, of Electrical Engineering and of Radiation Oncology (Radiation Therapy)
Current Research and Scholarly Interests1) Healthcare management: I am interested in improving healthcare delivery using data-driven modeling and decision-making.
2) Network models and message-passing algorithms: I work on graphical modeling ideas motivated from statistical physics and their applications in statistical inference.
3) Personalized decision-making: I work on machine learning and statistical challenges of personalized decision-making. The problems that I have worked on are primarily motivated by healthcare applications. -
Michael S Binkley, MD, MS
Assistant Professor of Radiation Oncology (Radiation Therapy)
BioDr. Binkley is a radiation oncologist specializing in lymphoma treatment and an assistant professor in the Stanford University School of Medicine Department of Radiation Oncology.
His clinical expertise includes stereotactic ablative radiotherapy (SABR), total lymphoid and total body irradiation, and intensity modulated radiation therapy (IMRT).
For each patient, Dr. Binkley develops a personalized, comprehensive, and compassionate care plan. His goals are to improve both health and quality of life.
Dr. Binkley has conducted extensive research to advance cancer treatment. In his post-doctoral fellowship at Stanford, he studied the use of genomic signatures to predict response to radiotherapy. His current clinical and laboratory research seek to identify prognostic and predictive clinical, radiographic, and genomic factors to inform individualized treatment strategies.
He has co-authored articles on his research discoveries published in Journal of Clinical Oncology, Cancer Discovery, Blood, the International Journal of Radiation Oncology*Biology*Physics, and elsewhere. Topics have included innovations in the treatment of lymphoma and lung cancer.
He also has made invited presentations to colleagues at national and international conferences. He has presented the latest findings on radiation therapy for lung cancer and lymphoma at meetings of the American Society of Clinical Oncology (ASCO), American Society for Radiation Oncology (ASTRO), and International Conference on Malignant Lymphoma (ICML).
Honors for Dr. Binkley include the Malcolm A. Bagshaw Award for leadership and outstanding scientific achievement. This award is named for a pioneer in radiation therapy and former chair of the Departments of Radiology and Radiation Oncology at Stanford University School of Medicine.
Dr. Binkley is a member of the American Society of Clinical Oncology, American Society for Radiation Oncology, and American Association for Cancer Research. He is a founding member of the Global nLPHL One Working (GLOW) Working Group, an international collaboration studying nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) in children and adults. -
Martin Brown
Professor of Radiation Oncology, Emeritus
Current Research and Scholarly InterestsWe seek to understand the mechanisms responsible for the resistance of cancers to treatment and to develop strategies to overcome these resistances. We are using molecular and cellular techniques and mouse models to potentiate the activity of radiation on tumors by inhibiting the bone marrow rescue of the tumor vasculature following therapy.
-
Santino S. Butler, MD
Clinical Assistant Professor, Radiation Oncology - Radiation Therapy
BioSantino Butler, MD, is a radiation oncologist who treats a broad range of malignancies, with a particular clinical focus in high-dose-rate brachytherapy for gynecologic cancers. He has published more than 30 peer-reviewed research articles, including first-author publications in several highly-cited medical journals such as the New England Journal of Medicine (NEJM), the Journal of the American Medical Association (JAMA), the Journal of the American Medical Association–Oncology (JAMA Oncology), and the Journal of the American College of Cardiology–CardioOncology (JACC CardioOncol); He has presented his work at several major medical conferences throughout the country.
-
Mark Buyyounouski, MD, MS, FASTRO
Professor of Radiation Oncology (Radiation Therapy)
Current Research and Scholarly InterestsPatient-centered and artificial intelligence-augmented medical decision making
-
Rishabh Chaudhari, MD
Clinical Assistant Professor, Radiation Oncology - Radiation Therapy
BioDr. Chaudhari is a radiation oncologist with the Stanford Medicine Cancer Center and a clinical assistant professor in the Department of Radiation Oncology at Stanford University School of Medicine.
In every case, he develops a comprehensive, compassionate care plan personalized to the unique needs of each patient. His goal is always to deliver innovative, compassionate care of the highest quality to help each patient achieve the best possible outcome.
Dr. Chaudhari conducts research into leading-edge treatments, allowing him to offer the most advanced care options. He has investigated stereotactic body radiation therapy for non-small cell lung cancer and for pancreatic adenocarcinoma. He has also studied the effects of radiotherapy on breast cancer stem cells and extramedullary plasmacytomas. He also is currently studying the use of proton beam therapy on recurrent head and neck cancers.
Dr. Chaudhari has presented his research findings at meetings of the Radiation Research Society, Society for Thermal Medicine, American Society for Radiation Oncology, and World Congress of Brachytherapy. He has published articles on radiotherapy for non-small cell lung cancer in the journal Lung Cancer: Targets and Therapy. He also co-authored the chapter “Renal and Adrenal Vasculature: Anatomy and Imaging” in the textbook Image-Guided Interventions. He has served as a reviewer for Cancer Medicine.
In previous positions, Dr. Chaudhari served on committees dedicated to care quality assurance and to the monitoring of cancer care protocols. Other areas of interest include radiation oncology department operations and advising radiation oncology residents.
Dr. Chaudhari is a member of the American Society for Radiation Oncology. -
Sijie Chen
Postdoctoral Scholar, Radiation Physics
BioI am a postdoctoral fellow working with Dr. Lei Xing at Stanford University, where I develop trustworthy autonomous AI agents and foundational informatics systems for single-cell biology. My long-term vision is to build auditable computational infrastructure and virtual cell models that transform massive single-cell atlases into reliable, steerable systems for mechanistic discovery across tissues, diseases, and species. My doctoral work with Prof. Xuegong Zhang established my foundation in single-cell bioinformatics and atlas-scale integration, which I have since extended into large-scale representation modeling, AI agent workflows, and LLM-driven scientific discovery. My current work focuses on developing governed, agentic lifecycles for continuous single-cell data curation and foundation model evaluation, while applying these autonomous systems to power cross-organ virtual cell retrieval and simulate immune-tolerance breakdown.
My ongoing efforts build directly upon my prior work in atlas integration and algorithmic development. As the first author of hECA (Chen et al., 2022), I built a unified human cell atlas integrating one million high-quality cells across 38 organs with a logic-expression query interface. This experience exposed the central bottlenecks—such as heterogeneous formats and ontology grounding—that I now address using LLM-powered agents to enable autonomous metadata harmonization and iterative quality control. I am converting manual curation into an autonomous, agent-driven paradigm where new datasets are continuously ingested and versioned in a traceable manner. Furthermore, my co-development of TorchGW for cell state alignment, TFcomb for perturbation prediction, and TransMap for cross-species alignment provides the algorithmic foundation for next-generation cell foundation models and virtual cell simulation.
By integrating these components into trustworthy, benchmarked, and human-in-the-loop AI infrastructure, my research bridges scalable scientific computing with complex biomedical questions. Through close collaboration with Prof. Edgar Engleman, I am utilizing immune-tolerance breakdown—specifically focusing on a tolerogenic dendritic cell program—as a mechanistic testbed to validate our virtual cell simulations. A core focus of my work is ensuring that every agent-generated hypothesis and retrieved state remains bound to the exact data and model checkpoints that produced it, making findings fully re-derivable as the biological knowledge base evolves. Ultimately, I aim to advance the frontier of trustworthy autonomous single-cell informatics, bridging AI agents, virtual cell engineering, and biological discovery. -
Wenting Chen
Postdoctoral Scholar, Radiation Physics
BioI am currently a Postdoc Fellow in the Department of Radiation Oncology of Stanford University, advised by Prof. Lei Xing. Before joining Stanford, I obtained my Ph.D degree in the Department of Electrical Engineering, City University of Hong Kong, supervised by Prof. Yixuan YUAN, Prof. W.S Tommy Chow, and Prof. L.H. Leanne Chan. I visited Massachusetts General Hospital and Harvard Medical School, supervised by Prof. Xiang Li and Prof. Quanzheng Li. Before that, I received the B. Eng and M. Eng degree from College of Computer Science and Software Engineering in Shenzhen University of China in 2017 and 2020, supervised by Prof. Linlin Shen. From Dec. 2019 to Nov. 2020, I had interned in Tencent Jarvis Lab, supervised by Dr. Shuang Yu and Prof. Yefeng Zheng.
My research interests lie in vision-language model, multi-modal large language model, generative AI, computer vision and their applications on medical AI, with a focus on report generation, medical image synthesis, endoscopy super-resolution, retinal image segmentation, multi-modality diagnosis, etc. -
Alexander Chin, MD, MBA
Clinical Associate Professor, Radiation Oncology - Radiation Therapy
BioAlexander Chin, MD, MBA, is a radiation oncologist with Stanford Medicine Cancer Center and a clinical associate professor in the Department of Radiation Oncology with the Stanford School of Medicine. He also serves as Executive Director of Market Development, Cancer Services for Stanford Health Care, acting as a liaison between faculty leadership and hospital administration, to advance Stanford Medicine’s mission of providing compassionate leading-edge care to the communities that we serve.
Dr. Chin is committed to ensuring the delivery of care of the highest quality and value. He provides clinical expertise in diagnosing and treating the full range of cancers, including those of the lung, breast, and central nervous system. In addition, he serves on national leadership teams formed to advance the practice of cancer care. Dr. Chin is currently a member of the Payment Reform Task Force for the American Society of Clinical Oncology and has previously served on their Clinical Practice Committee and as a health policy fellow. He was one of just two oncologists in the US selected to participate in a year-long program on policy leadership.
He currently serves on the Stanford Cancer Network Quality Committee. This team develops and implements our care delivery standards, strategies, and metrics to ensure consistently excellent cancer care from all Stanford Health Care providers in all locations.
Dr. Chin has conducted extensive research and published his findings in numerous peer-reviewed journals. Topics range from novel oncology payment models to the use of new imaging parameters in lung cancer. His scholarship appears in Cancer, JCO Oncology Practice, Clinical Lung Cancer, International Journal of Radiation Oncology, Biology, Physics, and elsewhere.
He has made presentations on stereotactic body radiotherapy (SBRT) and other treatment advances at meetings of the Radiological Society of North America and American Society for Radiation Oncology. He also has addressed these topics as an invited lecturer in training sessions for oncology residents.
He has won numerous awards, including recognition for his research from the Radiological Society of North America. He also has earned honors from the American Society of Clinical Oncology and from his alma maters: the Perelman School of Medicine at the University of Pennsylvania as well as Wharton and Yale.
Dr. Chin earned a Bachelor of Science degree in molecular biophysics and biochemistry from Yale University. He earned his medical degree from Perelman School of Medicine at the University of Pennsylvania, and his MBA at the Wharton School. He completed his residency in Radiation Oncology at Stanford Health Care.
He is a member of the Radiological Society of North America, American Society for Radiation Oncology, and American Society for Clinical Oncology. -
Cynthia Chuang
Clinical Professor, Radiation Oncology - Radiation Physics
BioEducation:
1990-B.S., Bioelectrical Engineering (6-1B), Massachusetts Institute of Technology, Cambridge, MA
1992-M.S., Bioengineering, University of Pennsylvania, Philadelphia, PA
1994-M.S., Nuclear Engineering (NMR Spectroscopy), Massachusetts Institute of Technology, Cambridge, MA
1999-Ph.D., Nuclear Engineering (Boron Neutron Capture Therapy), Massachusetts Institute of Technology, Cambridge, MA
2001-Postdoctoral Fellowship (Peregrine Project), Lawrence Livermore National Laboratory
2003-Medical Physics Residency, University of California, San Francisco (joint 3.5-year postdoctoral and residency program)
Academic Appointments:
2003 - 2005-Clinical Instructor, Radiation Oncology, University of California, San Francisco, San Francisco, California
2005 - 2009-Assistant Adjunct Professor, Radiation Oncology, University of California, San Francisco, San Francisco, California
2009 - 2013-Assistant Professor In Residence, Radiation Oncology, University of California, San Francisco, San Francisco, California
2013 - 2017-Associate Professor In Residence, Radiation Oncology, University of California, San Francisco, San Francisco, California
2017 - 2018-Associate Professor of Clinical Radiation Oncology, University of California, San Francisco, San Francisco, California
2019 - 2023-Clinical Associate Professor, Department of Radiation Oncology, Clinical Educator Line, Stanford University, Stanford, CA
2023- Present-Clinical Professor, Department of Radiation Oncology, Clinical Educator Line, Stanford University, Stanford, CA -
A. Dimitrios Colevas, MD
Professor of Medicine (Oncology) and, by courtesy, of Otolaryngology - Head & Neck Surgery (OHNS) and of Radiation Oncology (Radiation Therapy)
Current Research and Scholarly InterestsMulti- modality treatment of Head and Neck Cancer
Phase 1 clinical trials -
Xianjin Dai, PhD, DABR
Assistant Professor of Radiation Oncology (Radiation Physics)
Current Research and Scholarly InterestsIntelligent Image-guided intervention
AI in Medicine
Medical Image Analysis
Biomedical Physics
Multimodal Imaging
Ultrasound Imaging
Medical Device
Biomedical Optics (Optical, Photoacoustic, OCT) -
Niki DeGeorge
Associate Director of Radiation Physics, Radiation Oncology
Current Role at StanfordNiki is the Associate Director of Radiation Physics in the Department of Radiation Oncology.
-
Maximilian Diehn, MD, PhD
Jack, Lulu, and Sam Willson Professor and Professor of Radiation Oncology (Radiation Therapy)
Current Research and Scholarly InterestsMy laboratory focuses on two main areas: 1) cancer stem cell biology and 2) novel biomarkers for identifying the presence of malignant cells (diagnostic), predicting outcome (prognostic), and predicting response to therapy (predictive). Areas of study include cancers of the lung, breast, and gastrointestinal system. Clinically I specialize in the treatment of lung cancer and applications of stereotactic ablative radiotherapy and perform both prospective and retrospective clinical studies.
-
Frederick M. Dirbas, MD
Associate Professor of Surgery (General Surgery) and, by courtesy, of Radiation Oncology (Radiation Therapy)
Current Research and Scholarly InterestsCurrently collaborating with Dr's Aaron Newman and Michael Clarke to study cancer stem cells associated with triple negative breast cancer. Advancing studies of FLASH radiotherapy in preclinical models for potential future use in humans. Investigating preclinical use of high dose gaseous nitric oxide in the treatment of solid tumors.
-
Sarah S. Donaldson, MD
Catharine and Howard Avery Professor in the School of Medicine, Emerita
Current Research and Scholarly InterestsCombined Modality Treatment of Cancer
Late Effects of Treatment
Genetic Effects of Cancer
Rhabdomyosarcoma
Hodgkins Disease
Pediatric Radiation Oncolgy
Pediatric Oncolgy
Breast Cancer
Conformal Radiotherapy/IMRT
Radiotherapy for Benign Diseases -
Piotr Dubrowski
Clinical Instructor, Radiation Oncology - Radiation Physics
BioPiotr Dubrowski is a Canadian trained and board-certified Therapy Medical Physicist. Throughout his career Piotr has had the opportunity to bring several new Cancer Clinics operational from the ground up, where he was able to hone a broad, systems-approach to Radiation Oncology. He was recently promoted to Associate Quality Director of Physics responsible for improving patient safety and workflow/technology improvements across a wide cancer care network. Piotr’s research interests focus mainly on improving the treatment planning process and increasing clinic safety through software development and hardware 3D-print prototyping. Additionally, Piotr has sought out opportunities to give back to the Global community with participation in the Stanford Global Radiation Oncology Outreach efforts expanding education and access to care in Tanzania and Kenya and throughout the developing world via online Radiation Therapy courses.
-
Suparna Dutt
Senior Research Scientist, Radiation Oncology - Radiation Therapy
Current Role at StanfordSr Research Scientist
-
Sofia Ferreira
Postdoctoral Scholar, Radiation Biology
BioCancer Biology Scientist focused on improving treatment options on refractory tumors, primarily pancreatic cancer. My research focuses on uncovering innovative strategies to enhance the responsiveness of pancreatic cancer to existing treatments through fundamental research and preclinical approaches:
1.Investigate key molecular pathways in pancreatic cancer using in vivo, organelle-specific omics to identify new therapeutic targets
2.Identify unique drivers and tumor-stroma crosstalk across distinct pancreatic cancer subtypes
3.Exploit tumor cell innate immunity pathways to enhance pancreatic cancer responses to immunotherapy -
Marina Francis
Postdoctoral Scholar, Radiation Therapy
BioDr. Francis is a Postdoctoral Scholar in Dr. Everett Moding’s lab at the Department of Radiation Oncology. She uses genomic analysis of patient samples and preclinical models to identify new targets that sensitize sarcoma to treatments like radiation and immunotherapy. Before joining Stanford University, she completed her PhD in Biomedical Sciences at the American University of Beirut, where she worked in Dr. Youssef Zeidan’s lab investigating the role of the sphingolipid-modifying enzyme SMPDL3b in radiation nephropathy. Her research interests revolve around improving cancer treatment outcomes and patients’ quality of life by optimizing radiation therapy, combined treatment strategies, personalized precision oncology, and mitigating collateral treatment-associated toxicities.
-
Richard Frock
Assistant Professor of Radiation Oncology (Radiation and Cancer Biology)
Current Research and Scholarly InterestsWe are a functional genomics laboratory interested in elucidating mechanisms of DNA repair pathway choice and genome instability. We use genome-wide repair fate maps of targeted DNA double strand breaks (DSBs) to develop pathway-specific models and combinatorial therapies. Our expertise overlaps many different fields including: genome editing, ionizing radiation, cancer therapeutics, V(D)J and IgH class switch recombination, repair during transcription and replication, and meiosis.
-
Michael Gensheimer
Clinical Associate Professor, Radiation Oncology - Radiation Therapy
Current Research and Scholarly InterestsIn addition to my clinical research in head and neck and lung cancer, I work on the application of computer science and machine learning to cancer research. I develop tools for analyzing large datasets to improve outcomes and safety of cancer treatment. I developed a machine learning prognostic model using data from around 13,000 patients with metastatic cancer which performs better than traditional models and physicians [PubMed ID 33313792]. We recently completed a prospective randomized study in thousands of patients in which the model was used to help improve advance care planning conversations.
I also work on the methods underpinning observational and predictive modeling research. My open source nnet-survival software that allows use of neural networks for survival modeling has been used by researchers internationally. In collaboration with the Stanford Research Informatics Center, I examined how electronic medical record (EMR) survival outcome data compares to gold-standard data from a cancer registry [PubMed ID 35802836]. The EMR data captured less than 50% of deaths, a finding that affects many studies being published that use EMR outcomes data. -
Amato J. Giaccia
Jack, Lulu and Sam Willson Professor, Professor of Radiation Oncology, Emeritus
Current Research and Scholarly InterestsDuring the last five years, we have identified several small molecules that kill VHL deficient renal cancer cells through a synthetic lethal screening approach. Another major interest of my laboratory is in identifying hypoxia-induced genes involved in invasion and metastases. We are also investigating how hypoxia regulates gene expression epigenetically.
-
Iris C. Gibbs, MD, FACR, FASTRO
Professor of Radiation Oncology (Radiation Therapy) and, by courtesy, of Neurosurgery
Current Research and Scholarly InterestsDr. Gibbs is a board-certified radiation oncologist who specializes in the treatment of CNS tumors. Her research focuses on developing new radiation techniques to manage brain and spinal tumors in adults and children. Dr. Gibbs has gained worldwide acclaim for her expertise in Cyberknife robotic radiosurgery.
-
Edward Graves
Professor of Radiation Oncology (Radiation Physics), and by courtesy, of Radiology
Current Research and Scholarly InterestsApplications of molecular imaging in radiation therapy, small animal image-guided conformal radiotherapy, immune responses to radiation, immunotherapy and radiotherapy combinations, image processing and analysis.
